Bluejay Therapeutics Revenue and Competitors

Location

#3797

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Bluejay Therapeutics's estimated annual revenue is currently $3.9M per year.(i)
  • Bluejay Therapeutics's estimated revenue per employee is $94,512
  • Bluejay Therapeutics's total funding is $243M.

Employee Data

  • Bluejay Therapeutics has 41 Employees.(i)
  • Bluejay Therapeutics grew their employee count by 95% last year.

Bluejay Therapeutics's People

NameTitleEmail/Phone
1
Founder, CEO and ChairmanReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Chief Commercial OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Chief Commercial OfficerReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
SVP, Head FinanceReveal Email/Phone
9
Head ImmunologyReveal Email/Phone
10
VP, BiochemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Bluejay Therapeutics?

The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.

keywords:N/A

$243M

Total Funding

41

Number of Employees

$3.9M

Revenue (est)

95%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.4M41-16%$100.3M
#2
$8.9M41-5%N/A
#3
$4.6M41N/AN/A
#4
$4.4M41-31%$2.8M
#5
$4.5M4171%$45.1M